Ann Costello
Fortune : 50 965 $ au 31/08/2026
Fortune : 50 965 $ au 31/08/2026
Ann Costello is currently an Independent Director at Elekta AB since 2024, a Director at Ibex Medical Analytics Ltd., and an Independent Director at Freenome, Inc. starting in 2026.
Formerly, Ms. Costello was Head of Diagnostics Solutions Business at Roche Group from 2020 to 2023.
Education includes an undergraduate degree from Technological University Dublin.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/04/2026 | 9 000 ( 0% ) | 50 965 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ELEKTA AB | Directeur/Membre du Conseil | 01/09/2024 |
Ibex Medical Analytics Ltd.
Ibex Medical Analytics Ltd. Packaged SoftwareTechnology Services Develops and operates medical analysis platform for pathology and cancer diagnostics | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
Roche Group
Roche Group Real Estate DevelopmentFinance Manages real estate properties | Corporate Officer/Principal | 02/01/2023 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Elekta AB
Elekta AB Medical SpecialtiesHealth Technology Manufactures radiation oncology and neurosurgery instruments | Health Technology |
Roche Group
Roche Group Real Estate DevelopmentFinance Manages real estate properties | Finance |
Ibex Medical Analytics Ltd.
Ibex Medical Analytics Ltd. Packaged SoftwareTechnology Services Develops and operates medical analysis platform for pathology and cancer diagnostics | Technology Services |
Technological University Dublin
Technological University Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national